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hip arthroplasty. Cells were cultured in DMEM with 10% FCS con- 
taining CS (1-100 i~g/ml) with medium change every 2 days. Af- 
ter 4 days, culture medium was replaced with serum free DMEM 
containing 1% ITS with or without IL-11~ (1 ng/ml) and then, the 
incubation was further continued for 24 or 48 h. At the end of ex- 
periments, culture medium was harvested for HA assay, using an 
ELISA-like method. RNA was isolated and reverse transcribed to 
cDNA, which was then subjected to the relative quantitative real- 
time PCR (Q-RT-PCR) procedure, using the ABI PRISM 7000 
and SYBR green detection and specific primers for hyaluronan 
synthases (HAS) 1, 2 and 3 and UDP-glucose dehydrogenase 
(UGDH). RT-PCR data were normalized with GAPDH mRNA and 
gene expression relative to control was calculated with the delta 
delta cycle to threshold (ddCt) method. 
Results: IL-11~ was found to dramatically increase HA produc- 
tion by synoviocytes and articular chondrocytes. CS stimulated 
HA production by these cells, in a dose and time dependent 
manner. The effect of CS was observed for both basal and IL- 
l I~ induced HA levels. The cytokine increased mRNA expression 
of HAS1 and HAS2 in the two cell types, with greater effect on 
HAS1 than HAS2 whereas CS induced equivalent stimulation on 
both genes. As for HA production, the effect of CS on HAS1 and 
HAS2 expression was observed for basal and IL-11~ induced ex- 
pression. UGDH expression was stimulated by IL-11~ in chondro- 
cytes only. CS stimulated basal and IL-11~ induced mRNA expres- 
sion of UGDH in both synoviocytes and chondrocytes. Expres- 
sion of HAS3, rather implicated in synthesis of low molecular HA 
species, was found to be stimulated by IL-11~ in the two articular 
cells. Interestingly, CS inhibited HAS3 expression and repressed 
the IL-11~ induced stimulation of this gene in chondrocytes. Work 
is in progress to determine the molecular size of HA produced in 
these experimental conditions. 
Conclusion: CS enhanced HA production by articular cells. The 
effect is associated with concomitant increase of UGDH, HAS1 
and HAS2 mRNA expression. In contrast, the expression of 
HAS3, the enzyme involved in synthesis of low molecular forms 
of HA is depressed by CS. These findings suggest that CS could 
exert its beneficial effect on OA symptoms through increased HA 
release in the synovial fluid and enhanced aggregating potential 
for cartilage proteoglycans. 
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Aim: The aim of this study was to compare a synthetic Hyaluro- 
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nan (OstenilP TMP) to a corticosteroid injection (Depomedrone) for 
primary subacromial impingement of the shoulder. 
Methods: In a retrospective review, thirty one patients with pri- 
mary subacromial impingement of the shoulder were randomly 
given either a 40mg Depomedrone injection or Ostenil injection. 
No patients had undergone previous surgery. All had physiother- 
apy following the injection. Patients were given a Pain Diary with 
a ten point visual analogue scale to complete. 
Results: There was no difference between the two groups with 
regard to age and sex. 
Both steroid and Ostenil reduce the pain score in the first two 
to four hours post-injection, but in the Depomedrone group the 
pain score increases significantly from 12 hours to 2 days post- 
injection. This effect is not observed with Ostenil. This differ- 
ence is significant (p<0.05) between 18 hours and 3 days post- 
injection. From 4 days the pain score is similar, with an equal 
reduction in pain in the two groups. 
Conclusions: Ostenil Hyaluronan appears to be as effective as 
Depomedrone in reducing subacromial impingement pain, but 
does not produce the pain surge associated with Depomedrone 
in the first few days post-injection. 
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Background: The WOMAC questionnaire has three sections: 
pain, stiffness, and function. The original function section (sec- 
tion C) has 17 items but shortened versions with eight and nine 
items have recently been proposed. 
Aims: To assess and compare construct validity of the 17, nine, 
and 8eight-item versions of the WOMAC questionnaire. 
Methods: In a cross sectional national survey, 1811 GPs enrolled 
5324 patients with hip and/or knee osteoarthritis (OA). Pain at 
rest and during activities, and mean pain for the previous eight 
days were recorded on a 11-point numeric scale, and function 
was assessed using the 17, nine, and eight item-versions of the 
WOMAC, section C. Construct validity was assessed using the 
Chronbach coefficient, and factor analysis followed by orthogo- 
nal rotation. Coefficient correlations between mean scores were 
determined with Spearman's rank correlation coefficient. 
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Abstract P153 - Fig. I. Mean VAS scores over time. 
